Effect of L-ornithine-L-aspartate on Liver Fuction after Hemihepatectomy in Patients with Hepatocel-lular Carcinoma and Liver Cirrhosis

王建,史瑞,王连江,吴迪,崔子林,李阳,侯建存,田青,刘晓龙,张雅敏
DOI: https://doi.org/10.3969/j.issn.1007-6948.2014.04.003
2014-01-01
Abstract:Objective To investigate the effect of L-ornithine-L-aspartate on liver fuction after hemihepa-tectomy in patients with hepatocellular carcinoma and liver cirrhosis. Methods The clinical data of 66 pa-tients receiving hepatectomy were analyzed. The patients were divided into the experimental group (n=33) and control group (n=33). L-ornithine-L-aspartate was injected intravenously in the experimental group from the 1st to the 7th day after operation. The blood levels of serum alanine aminotransferase (ALT), aspartic acid amino-transferase (AST), total bilirubin (TB) and direct bilirubin (DB) were detected at day 1,3,5,7,10,14 after opera-tion. Results In the experimental group,the levels of AST on 1st,3rd and 5th day and of ALT on 3rd and 5th day after operation were significantly lower in the experimental group than those in the control group (P<0.05). On the postoperative day 7,the ratio of serum ALT in the experimental group returned to normal was sig-nificantly higher than that in the control group (P<0.05). There was no difference between the 2 groups in the levels of TB and DB after operation. The incidence of liver failure after operation was slightly lower in the experi-mental group than that in the control group (P=0. 557). Conclusion L-ornithine-L-aspartate can alleviate the hepatic dysfunction after hemihepatectomy,and has protective advantage for liver function in the periopera-tive period of hemihepatectomy.
What problem does this paper attempt to address?